Literature DB >> 21654209

Requirement of evading apoptosis for HIF-1α-induced malignant progression in mouse cells.

Masami Hayashi1, Yoo Young-Gun Yoo, Jared Christensen, L Eric Huang.   

Abstract

Tumor hypoxia is correlated with genetic alteration and malignant progression. Our previous studies indicated that the hypoxia-inducible transcription factor, HIF-1α, is responsible for hypoxic suppression of DNA repair in tumor cells by a non-canonical mode of action that requires the HIF-1α PAS-B subdomain. The involvement of HIF-1α in genetic alteration has raised an intriguing question as to whether normal cells would respond to hypoxic stress differently to avert genetic alteration. In this study, we chose several mouse cell types ranging from benign to malignant, apoptosis-proficient to apoptosis-deficient, and determined their responses to HIF-1α expression. In agreement with our previous findings, transient hypoxia and HIF-1α expression inhibited DNA repair and induced DNA damage in all cell types examined; however, cumulative DNA damage only occurred in apoptosis-deficient, malignant cells transduced for sustained expression of HIF-1α or HIF-1α PAS-B itself. In keeping with the theory of apoptosis as a cancer barrier, only these apoptosis-deficient cells acquired anchorage-independent growth and epithelial-mesenchymal transition. Furthermore, these cells exhibited increased Akt activity and resistance to etoposide by inhibiting autophagy. Altogether, our results define an essential role for apoptosis to prevent HIF-1α-induced genetic alteration and thereby malignant progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21654209      PMCID: PMC3322472          DOI: 10.4161/cc.10.14.16313

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  39 in total

Review 1.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

2.  A simple technique for quantitation of low levels of DNA damage in individual cells.

Authors:  N P Singh; M T McCoy; R R Tice; E L Schneider
Journal:  Exp Cell Res       Date:  1988-03       Impact factor: 3.905

Review 3.  Modelling the molecular circuitry of cancer.

Authors:  William C Hahn; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

4.  Leu-574 of human HIF-1alpha is a molecular determinant of prolyl hydroxylation.

Authors:  Yukio Kageyama; Minori Koshiji; Kenneth K W To; Ya-Min Tian; Peter J Ratcliffe; L Eric Huang
Journal:  FASEB J       Date:  2004-04-14       Impact factor: 5.191

5.  HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.

Authors:  Minori Koshiji; Yukio Kageyama; Erin A Pete; Izumi Horikawa; J Carl Barrett; L Eric Huang
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

Review 6.  HIF-1 and hypoxic response: the plot thickens.

Authors:  Lorenz Poellinger; Randall S Johnson
Journal:  Curr Opin Genet Dev       Date:  2004-02       Impact factor: 5.578

7.  Hypoxia and defective apoptosis drive genomic instability and tumorigenesis.

Authors:  Deirdre A Nelson; Ting-Ting Tan; Arnold B Rabson; Diana Anderson; Kurt Degenhardt; Eileen White
Journal:  Genes Dev       Date:  2004-08-16       Impact factor: 11.361

8.  Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.

Authors:  Lin Yang; Han C Dan; Mei Sun; Qiyuan Liu; Xia-meng Sun; Richard I Feldman; Andrew D Hamilton; Mark Polokoff; Santo V Nicosia; Meenhard Herlyn; Said M Sebti; Jin Q Cheng
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

9.  The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.

Authors:  M Ohta; H Inoue; M G Cotticelli; K Kastury; R Baffa; J Palazzo; Z Siprashvili; M Mori; P McCue; T Druck; C M Croce; K Huebner
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

10.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.

Authors:  T G Graeber; C Osmanian; T Jacks; D E Housman; C J Koch; S W Lowe; A J Giaccia
Journal:  Nature       Date:  1996-01-04       Impact factor: 49.962

View more
  4 in total

1.  The HIF-1α-c-Myc pathway and tumorigenesis: evading the apoptotic gate-keeper.

Authors:  Nicole Fer; Giovanni Melillo
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

2.  Intermittent induction of HIF-1α produces lasting effects on malignant progression independent of its continued expression.

Authors:  Hyunsung Choi; David L Gillespie; Shauna Berg; Christopher Rice; Sandrine Couldwell; Jie Gu; Howard Colman; Randy L Jensen; L Eric Huang
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

3.  Tumor hypoxia as a driving force in genetic instability.

Authors:  Kaisa R Luoto; Ramya Kumareswaran; Robert G Bristow
Journal:  Genome Integr       Date:  2013-10-24

Review 4.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.